8-K: Ryan Specialty Reports Strong First Quarter 2024 Results, Driven by Double-Digit Organic Growth

Ryan Specialty announced a robust start to 2024 with a 20.6% increase in total revenue and a 13.7% organic revenue growth rate for the first quarter.

Summary

• Ryan Specialty reported a 20.6% year-over-year increase in total revenue, reaching $552.0 million for the first quarter of 2024.
• The company's organic revenue growth rate was 13.7%, driven by new client wins and expanded relationships with existing clients.
• Net income for the quarter increased by 11.6% to $40.7 million, or $0.13 per diluted share.
• Adjusted EBITDAC grew by 25.8% year-over-year to $157.2 million, with an adjusted EBITDAC margin of 28.5%.
• Adjusted net income rose by 32.9% to $95.4 million, or $0.35 per diluted share.
• The company returned $45.6 million to shareholders and LLC unit holders through special and regular dividends and distributions.
• Ryan Specialty updated its ACCELERATE 2025 restructuring program, expecting $110 million in cumulative one-time charges through 2024 and $60 million in annual savings in 2025.
• A regular quarterly dividend of $0.11 per share on Class A common stock was declared, payable on May 28, 2024.

Sentiment

Score: 9

Explanation: The document conveys a very positive sentiment due to strong financial results, significant growth metrics, and strategic acquisitions. The company's outlook is also optimistic, contributing to the high sentiment score.

Positives

• Ryan Specialty experienced strong revenue growth across most of its property and casualty lines.
• The company's adjusted EBITDAC margin expanded by 120 basis points.
• The acquisition of Castel is expected to bolster the company's delegated authority offering and expand its market reach.
• The company is maintaining its full-year 2024 outlook for organic revenue growth rate and adjusted EBITDAC margin.
• The company's revised calculation methodology for organic revenue growth is considered more robust and representative of core business performance.

Negatives

• Total operating expenses increased by 23.7% due to higher compensation and restructuring costs.
• General and administrative expenses increased due to professional services, travel, and acquisition-related expenses.
• Net income margin decreased slightly from 8.0% to 7.4% year-over-year.
• The ACCELERATE 2025 program will incur approximately $110 million in one-time charges through 2024.

Risks

• The company's forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially.
• Risks include the achievement of objectives with the ACCELERATE 2025 program, the costs associated with restructuring initiatives, and the ability to realize expected savings.
• Other risks include those associated with acquisitions, divestitures, legal and regulatory matters, and changes in legislation or regulations.
• The company's inability to provide a comparable outlook for total revenue growth rate or net income margin is due to the difficulty in forecasting certain reconciling items.

Future Outlook

The company is maintaining its full-year 2024 outlook for organic revenue growth rate between 12.5% and 14.0% and adjusted EBITDAC margin between 31.0% and 31.5%.

Management Comments

• Patrick G. Ryan, Founder, Chairman and Chief Executive Officer, stated that the company had a great start to 2024, driven by double-digit organic growth and margin enhancement.
• He highlighted the 13.7% organic revenue growth, 120-basis point expansion of the adjusted EBITDAC margin, and 34.6% growth in adjusted diluted EPS.
• He also noted that the company's success is broad-based across its specialties and includes contributions from recent acquisitions.
• He expressed confidence that 2024 will be another outstanding year for the firm.

Industry Context

This announcement reflects a strong performance in the specialty insurance sector, with Ryan Specialty demonstrating significant growth in revenue and profitability. The acquisition of Castel also indicates a strategic move to expand its international presence and underwriting capabilities, which is a common trend in the industry.

Comparison to Industry Standards

• Ryan Specialty's 13.7% organic revenue growth rate is strong compared to many of its peers in the insurance brokerage industry, which often see single-digit growth rates.
• Companies like Brown & Brown and Marsh & McLennan Companies, while larger, have shown organic growth rates in the mid-single digits in recent quarters.
• The 25.8% growth in Adjusted EBITDAC and 32.9% growth in Adjusted Net Income are also impressive, indicating strong operational efficiency and profitability compared to industry averages.
• The adjusted EBITDAC margin of 28.5% is competitive, with some peers having margins in the high 20s or low 30s, but Ryan Specialty's growth rate is a key differentiator.
• The acquisition of Castel is similar to moves by other large brokers to expand their international footprint and underwriting capabilities, such as Aon's acquisition of CoverWallet.

Stakeholder Impact

• Shareholders will benefit from the increased profitability and the declared dividend.
• Employees may benefit from the company's growth and the success of the ACCELERATE 2025 program.
• Customers will likely benefit from the company's expanded capabilities and services.
• Suppliers and creditors may see increased business opportunities with the company's growth.

Next Steps

• The company will continue to execute its ACCELERATE 2025 program to drive growth and improve margins.
• Ryan Specialty will host a conference call to discuss these results.
• The company will pay a regular quarterly dividend on May 28, 2024.

Key Dates

Keywords

insurance, specialty insurance, wholesale brokerage, underwriting management, organic growth, EBITDAC, revenue, dividends, acquisitions, restructuring